首页> 外文会议>Proceedings of the 11th IEEE Annual International Conference on Nano/Micro Engineered and Molecular Systems >An integrated microfluidic system for screening of peptides specific to cholangiocarcinoma (CCA) cancer cell lines using the phage display technology
【24h】

An integrated microfluidic system for screening of peptides specific to cholangiocarcinoma (CCA) cancer cell lines using the phage display technology

机译:使用噬菌体展示技术筛选胆管癌(CCA)癌细胞系特异肽的集成微流系统

获取原文
获取原文并翻译 | 示例

摘要

Cholangiocarcinoma (CCA) is a cancer of bile duct, which possesses a high mortality rate and poor prognosis owing to its difficulties in early diagnosis and a lack of effective treatment. To improve the clinical detection, one of promising approaches is to find specific biomarkers to detect CCA cells. However, the existing screening processes are usually time-consuming and lab-intensive. In this study, an integrated microfluidic system was proposed to perform on-chip phage display for selection of specific peptides that could identify CCA cell lines. The results showed that we could perform one panning round within 6 hours and the whole processes could be automated. This microfluidic system may be a powerful tool for screening of affinity agents in the clinical diagnosis and target therapeutics for CCA.
机译:胆管癌(CCA)是一种胆管癌,由于其早期诊断困难和缺乏有效的治疗方法,因此死亡率高,预后差。为了改善临床检测,一种有前途的方法是找到特定的生物标志物来检测CCA细胞。但是,现有的筛选过程通常很耗时且需要大量实验室。在这项研究中,提出了一种集成的微流控系统来执行芯片上噬菌体展示,以选择可以鉴定CCA细胞系的特定肽。结果表明,我们可以在6小时内执行一轮平移,并且整个过程可以自动化。该微流体系统可能是用于在临床诊断和CCA靶向治疗中筛选亲和剂的有力工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号